2-HYDROXYPROPYL-β-CYCLODEXTRIN (HPβCD) FOR USE IN THE TREATMENT OF BREAST CANCER Application WO-2020157651-A1 World Intellectual Property Organisation (WIPO) 06 Aug 2020
MUTANT SELECTIVITY AND COMBINATIONS OF A PHOSPHOINOSITIDE-3-KINASE INHIBITOR COMPOUND AND… Application RU-2665949-C2 Russian Federation 05 Sep 2018
MUTANT SELECTIVITY AND COMBINATIONS OF A PHOSPHOINOSITIDE 3 KINASE INHIBITOR COMPOUND AND… Application WO-2013182668-A1 World Intellectual Property Organisation (WIPO) 12 Dec 2013